I dont believe that this is uncommon in neuro drugs. Mechanism of action looks at how the drug produces its effect. Trofinetide produces its effect by interacting with the chemicals in the brain rather than binding to a specific enzyme (which would be part of targeted treatment- eg cancer cells). For that reason the mechanism of action is unknown.
Ive heard Steve Davis mention this before and dont believe its a concern at all.
I dont believe that this is uncommon in neuro drugs. Mechanism...
-
- There are more pages in this discussion • 673 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |